Skip to main content

Advertisement

Log in

Biopharmaceutical, Toxicological, and Morphological Assessment of an Antiallergenic Medicine for External Application

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This report addresses studies of the release of active ingredients (diphenhydramine and fluconazole) from a gel base for a medicine for external application for the treatment of allergy complicated by fungal infection; its toxicological and morphological properties were studied. The gel composition was found to be a medicinal formulation providing complete release of the active components from the gel: the quantity of diphenhydramine released in 3 h approached 75%, while the quantity of fluconazole approached 72%. Active substances are easily released from this formation on application to the skin surface, with accumulation of drug to high concentrations at the lesion site. The gel composition was found to belong to class VI, relatively harmless substances, without toxic or cumulative actions. Skin histology results from experimental animals confirmed rapid regeneration of skin lesions on external application of the gel composition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. D. Rigopoulos and G. Larios, Acta Derm. Venereol., Supplement 216, 7 – 13 (2008).

  2. L. A. Khaertdinova and T. G. Malanicheva, Fundament. Issled., 7 – 1, 211 – 214 (2012).

  3. P. G. Bowler, J. Wound Care, 27, No. 5, 273 – 277 (2018); doi: https://doi.org/10.12968/jowc2018275273.

    Article  PubMed  Google Scholar 

  4. O. R. Akhmedov, Chemistry for Sustainable Development, No. 25, 341 – 345 (2017); doi: https://doi.org/10.15372/CSD20170401.

  5. N. N. Filimonkova, E. A. Bakhlykova, and M. S. Kolbina, Klin. Dermatol. Venerol., 1, 69 – 77 (2016); doi: https://doi.org/10.17116/klinderma201615169-77.

  6. Z. D. Khadzhieva, V. A. Chumakova, and L. B. Gubanova, Sovrem. Prob. Nauki Obraz., No. 1 – 2, 232 (2015).

  7. V. V. Gladyshev, Kuban. Nauch. Med. Vestn., No. 5 (140), 69 – 73 (2013).

  8. A. N. Mironov, Guidelines for Preclinical Studies of Drugs [in Russian], Grif i K., Moscow (2013), Part 1.

  9. T. A. Gus’kova, Drug Toxicology [in Russian], Moscow (2008), pp. 27 – 30.

  10. A. V. Stefanov, Preclinical Studies of Drugs (Methodological Guidelines) [in Russian], Kiev (2002).

  11. R. K. Lim and K. G. Rinketal, Arch. Int. Pharmacodyn., 130(1), 336 – 353 (1961).

    CAS  PubMed  Google Scholar 

  12. Republic of Uzbekistan Patent No. IAR 05327 (2017).

  13. A. V. Filatova, A. S. Turaev, D. T. Dzhurabaev, and L. B. Azimova, Khim.-Farm. Zh., 54(11), 53 – 56 (2020); doi: https://doi.org/10.30906/0023-1134-2020-54-11-53-56; Pharm. Chem. J., 54(11), 1169 – 1172 (2021).

  14. A. V. Filatova, A. S. Turaev, and N. L. Vypova, Khim.-Farm. Zh., 54(8), 29 – 34 (2020); doi: https://doi.org/10.30906/0023-1134-2020-54-8-29-34; Pharm. Chem. J., 54(8), 822 – 826 (2020).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. B. Azimova.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 1, pp. 19 – 24, January, 2022.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Filatova, A.V., Azimova, L.B. & Turaev, A.S. Biopharmaceutical, Toxicological, and Morphological Assessment of an Antiallergenic Medicine for External Application. Pharm Chem J 56, 16–21 (2022). https://doi.org/10.1007/s11094-022-02595-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02595-1

Keywords

Navigation